Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy.
Long-acting nanoformulated antiretroviral therapy (nanoART) induces a range of innate immune migratory, phagocytic and secretory cell functions that perpetuate drug depots. While recycling endosomes serve as the macrophage subcellular depots, little is known of the dynamics of nanoART-cell interacti...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2015-01-01
|
| Series: | PLoS ONE |
| Online Access: | http://europepmc.org/articles/PMC4696780?pdf=render |
| _version_ | 1819240364339363840 |
|---|---|
| author | Andrea L Martinez-Skinner Mariluz A Araínga Pavan Puligujja Diana L Palandri Hannah M Baldridge Benson J Edagwa JoEllyn M McMillan R Lee Mosley Howard E Gendelman |
| author_facet | Andrea L Martinez-Skinner Mariluz A Araínga Pavan Puligujja Diana L Palandri Hannah M Baldridge Benson J Edagwa JoEllyn M McMillan R Lee Mosley Howard E Gendelman |
| author_sort | Andrea L Martinez-Skinner |
| collection | DOAJ |
| description | Long-acting nanoformulated antiretroviral therapy (nanoART) induces a range of innate immune migratory, phagocytic and secretory cell functions that perpetuate drug depots. While recycling endosomes serve as the macrophage subcellular depots, little is known of the dynamics of nanoART-cell interactions. To this end, we assessed temporal leukocyte responses, drug uptake and distribution following both intraperitoneal and intramuscular injection of nanoformulated atazanavir (nanoATV). Local inflammatory responses heralded drug distribution to peritoneal cell populations, regional lymph nodes, spleen and liver. This proceeded for three days in male Balb/c mice. NanoATV-induced changes in myeloid populations were assessed by fluorescence-activated cell sorting (FACS) with CD45, CD3, CD11b, F4/80, and GR-1 antibodies. The localization of nanoATV within leukocyte cell subsets was determined by confocal microscopy. Combined FACS and ultra-performance liquid chromatography tandem mass-spectrometry assays determined nanoATV carriages by cell-based vehicles. A robust granulocyte, but not peritoneal macrophage nanoATV response paralleled zymosan A treatment. ATV levels were highest at sites of injection in peritoneal or muscle macrophages, dependent on the injection site. The spleen and liver served as nanoATV tissue depots while drug levels in lymph nodes were higher than those recorded in plasma. Dual polymer and cell labeling demonstrated a nearly exclusive drug reservoir in macrophages within the liver and spleen. Overall, nanoART induces innate immune responses coincident with rapid tissue macrophage distribution. Taken together, these works provide avenues for therapeutic development designed towards chemical eradication of human immunodeficiency viral infection. |
| first_indexed | 2024-12-23T14:06:50Z |
| format | Article |
| id | doaj.art-4edb165520984c83af62b4a2df1b1354 |
| institution | Directory Open Access Journal |
| issn | 1932-6203 |
| language | English |
| last_indexed | 2024-12-23T14:06:50Z |
| publishDate | 2015-01-01 |
| publisher | Public Library of Science (PLoS) |
| record_format | Article |
| series | PLoS ONE |
| spelling | doaj.art-4edb165520984c83af62b4a2df1b13542022-12-21T17:44:10ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014596610.1371/journal.pone.0145966Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy.Andrea L Martinez-SkinnerMariluz A AraíngaPavan PuligujjaDiana L PalandriHannah M BaldridgeBenson J EdagwaJoEllyn M McMillanR Lee MosleyHoward E GendelmanLong-acting nanoformulated antiretroviral therapy (nanoART) induces a range of innate immune migratory, phagocytic and secretory cell functions that perpetuate drug depots. While recycling endosomes serve as the macrophage subcellular depots, little is known of the dynamics of nanoART-cell interactions. To this end, we assessed temporal leukocyte responses, drug uptake and distribution following both intraperitoneal and intramuscular injection of nanoformulated atazanavir (nanoATV). Local inflammatory responses heralded drug distribution to peritoneal cell populations, regional lymph nodes, spleen and liver. This proceeded for three days in male Balb/c mice. NanoATV-induced changes in myeloid populations were assessed by fluorescence-activated cell sorting (FACS) with CD45, CD3, CD11b, F4/80, and GR-1 antibodies. The localization of nanoATV within leukocyte cell subsets was determined by confocal microscopy. Combined FACS and ultra-performance liquid chromatography tandem mass-spectrometry assays determined nanoATV carriages by cell-based vehicles. A robust granulocyte, but not peritoneal macrophage nanoATV response paralleled zymosan A treatment. ATV levels were highest at sites of injection in peritoneal or muscle macrophages, dependent on the injection site. The spleen and liver served as nanoATV tissue depots while drug levels in lymph nodes were higher than those recorded in plasma. Dual polymer and cell labeling demonstrated a nearly exclusive drug reservoir in macrophages within the liver and spleen. Overall, nanoART induces innate immune responses coincident with rapid tissue macrophage distribution. Taken together, these works provide avenues for therapeutic development designed towards chemical eradication of human immunodeficiency viral infection.http://europepmc.org/articles/PMC4696780?pdf=render |
| spellingShingle | Andrea L Martinez-Skinner Mariluz A Araínga Pavan Puligujja Diana L Palandri Hannah M Baldridge Benson J Edagwa JoEllyn M McMillan R Lee Mosley Howard E Gendelman Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy. PLoS ONE |
| title | Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy. |
| title_full | Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy. |
| title_fullStr | Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy. |
| title_full_unstemmed | Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy. |
| title_short | Cellular Responses and Tissue Depots for Nanoformulated Antiretroviral Therapy. |
| title_sort | cellular responses and tissue depots for nanoformulated antiretroviral therapy |
| url | http://europepmc.org/articles/PMC4696780?pdf=render |
| work_keys_str_mv | AT andrealmartinezskinner cellularresponsesandtissuedepotsfornanoformulatedantiretroviraltherapy AT mariluzaarainga cellularresponsesandtissuedepotsfornanoformulatedantiretroviraltherapy AT pavanpuligujja cellularresponsesandtissuedepotsfornanoformulatedantiretroviraltherapy AT dianalpalandri cellularresponsesandtissuedepotsfornanoformulatedantiretroviraltherapy AT hannahmbaldridge cellularresponsesandtissuedepotsfornanoformulatedantiretroviraltherapy AT bensonjedagwa cellularresponsesandtissuedepotsfornanoformulatedantiretroviraltherapy AT joellynmmcmillan cellularresponsesandtissuedepotsfornanoformulatedantiretroviraltherapy AT rleemosley cellularresponsesandtissuedepotsfornanoformulatedantiretroviraltherapy AT howardegendelman cellularresponsesandtissuedepotsfornanoformulatedantiretroviraltherapy |